Trials / Completed
CompletedNCT03416296
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
Evaluation of Role of Ultrasound TA,TV,TP in Diagnosis of Placenta Previa and MAP(Morbidly Adherent Placenta )
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 43 Years
- Healthy volunteers
- Accepted
Summary
Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.
Detailed description
The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.
Conditions
Timeline
- Start date
- 2018-03-15
- Primary completion
- 2019-06-10
- Completion
- 2019-12-20
- First posted
- 2018-01-31
- Last updated
- 2021-09-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03416296. Inclusion in this directory is not an endorsement.